Michael Kaleko

Statistics

Publications

Citations

4.7K

H-Index

Active since

1982

Affiliations

Research Institute for Genetic and Human Therapy(Current)

Novartis (United States)

Synthetic Biologics (United States)

Fred Hutch Cancer Center

Advanced Vision Institute

Michael Kaleko is an author at Research Institute for Genetic and Human Therapy specializing in life sciences, molecular biology, and adenoviral vectors.

ORCID

Publications per year

1982–2020

Publications

Overexpression of the human insulinlike growth factor I receptor promotes ligand-dependent neoplastic transformation.

Michael Kaleko, William J. Rutter, A. Dusty Miller · Molecular and Cellular Biology · 1990 · 399 citations · Full text

Medicine, Cell Biology, Oncology +17

Adenovirus mediated expression of therapeutic plasma levels of human factor IX in mice

Theodore A Smith, Michele G. Mehaffey, Dawn B. Kayda et al. · Nature Genetics · 1993 · 342 citations

Life Sciences, Molecular Biology, Molecular Pharmaceutics +10

Adenovirus Serotype 5 Fiber Shaft Influences <i>In Vivo</i> Gene Transfer in Mice

Theodore A Smith, Neeraja Idamakanti, Michele L. Rollence et al. · Human Gene Therapy · 2003 · 214 citations

Life Sciences, Molecular Biology, Cell Adhesion +15

Transformation mediated by the human HER-2 gene independent of the epidermal growth factor receptor.

V R Chazin, Michael Kaleko, A. Dusty Miller et al. · PubMed · 1992 · 172 citations

Medicine, Genetics, Molecular Biology +11

Receptor Interactions Involved in Adenoviral-Mediated Gene Delivery After Systemic Administration in Non-Human Primates

Theodore A Smith, Neeraja Idamakanti, Jennifer Marshall-Neff et al. · Human Gene Therapy · 2003 · 136 citations

Pharmacy, Molecular Biology, Pharmacology +17

1–5 of 61